Explore the Fingerprint Trends
Explore the Research Network
This is a list of publications by this organization, listed chronologically starting with the most recent first. The source of publications may be a combination of Scopus and manually entered data from a user. New publications from Scopus appear in this list weekly and publications entered by a user appear instantly. Citation counts start from 1996 and come directly from Scopus.
Aaron Sabolch; Tobias Else; Kent A. Griffith; Edgar Ben-Josef; Andrew Williams; Barbra S. Miller; Francis Worden; Gary D. Hammer; Shruti Jolly
Adjuvant radiation therapy improves local control after surgical resection in patients with localized adrenocortical carcinoma
Jon Oscherwitz; Conrad P. Quinn; Kemp B. Cease
Anthrax vaccine recipients lack antibody against the loop neutralizing determinant: A protective neutralizing epitope from Bacillus anthracis protective antigen
Morgan Jones; Jennifer Chase; Michelle Brinkmeier; Jing Xu; Daniel N. Weinberg; Julien Schira; Ann Friedman; Sami Malek; Jolanta Grembecka; Tomasz Cierpicki; et al.
Ash1l controls quiescence and self-renewal potential in hematopoietic stem cells
Yaping Sun; Ying Wang; Tomomi Toubai; Katherine Oravecz-Wilson; Chen Liu; Nathan Mathewson; Julia Wu; Corinne Rossi; Emily Cummings; Depei Wu; et al.
BET bromodomain inhibition suppresses graft-versus-host disease after allogeneic bone marrow transplantation in Mice
Amir Goldkorn; Benjamin Ely; Catherine M. Tangen; Yu-Chong Tai; Tong Xu; Hongli Li; Przemyslaw Twardowski; Peter J. Van Veldhuizen; Neeraj Agarwal; Michael A. Carducci; et al.
Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: A phase III metastatic castration resistant prostate cancer trial
Brian Leyland-Jones; Kathryn P. Gray; Mark Abramovitz; Mark Bouzyk; Brandon Young; Bradley Long; Roswitha Kammler; Patrizia Dell’Orto; Maria Olivia Biasi; Beat Thürlimann; et al.
CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1–98 trial
Megan E. V. Caram; Cui Guo; Monika Leja; Jeffrey Smerage; N. Lynn Henry; Donald Giacherio; Melvyn Rubenfire; Anne Schott; Melinda Davis; Daniel F. Hayes; et al.
Doxorubicin-induced cardiac dysfunction in unselected patients with a history of early-stage breast cancer
B. Boylan; A.S. Rice; C. De Staercke; M.E. Eyster; H.M. Yaish; C.M. Knoll; C.J. Bean; C.H. Miller; Thomas C. Abshire; Amy Dunn; et al.
Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations
Christine M. Veenstra; Andrew J. Epstein; Kaijun Liao; Jennifer J. Griggs; Craig E. Pollack; Katrina Armstrong
Hospital academic status and value of care for nonmetastatic colon cancer
Faith I. Umoh; Ikuko Kato; Jianwei Ren; Phillip L. Wachowiak; Mack T. Ruffin; D. Kim Turgeon; Ananda Sen; Dean E. Brenner; Zora Djuric
Markers of systemic exposures to products of intestinal bacteria in a dietary intervention study
Robert J. Motzer; Brian I. Rini; David F. McDermott; Bruce G. Redman; Timothy M. Kuzel; Michael R. Harrison; Ulka N. Vaishampayan; Harry A. Drabkin; Saby George; Theodore F. Logan; et al.
Nivolumab for metastatic renal cell carcinoma: Results of a randomized phase II trial
Alexis J. Carulli; Theresa M. Keeley; Elise S. Demitrack; Jooho Chung; Ivan Maillard; Linda C. Samuelson
Notch receptor regulation of intestinal stem cell homeostasis and crypt regeneration
Ronan T. Swords; Harry P. Erba; Daniel J. Deangelo; Dale L. Bixby; Jessica K. Altman; Michael Maris; Zhaowei Hua; Stephen J. Blakemore; Hélène Faessel; Farhad Sedarati; et al.
Pevonedistat (MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: A phase 1 study
Sara I. McClelland; Kathryn J. Holland; Jennifer J. Griggs
Quality of life and metastatic breast cancer: the role of body image, disease site, and time since diagnosis
Martin J. Edelman; Ming T. Tan; Mary J. Fidler; Rachel E. Sanborn; Greg Otterson; Lecia V. Sequist; Tracey L. Evans; Bryan J. Schneider; Roger Keresztes; John S. Rogers; et al.
Randomized, double-blind, placebo-controlled, multicenter phase ii study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancer
James M. Rae; Brian Leyland-Jones; Meredith Regan; Alastair M. Thompson
RE: Loss of heterozygosity at the CYP2D6 locus in breast cancer: Implications for germline pharmacogenetic studies
Yu-Chih Chen; Steven G. Allen; Patrick N. Ingram; Ronald Buckanovich; Sofia D. Merajver; Euisik Yoon
Single-cell migration chip for chemotaxis-based microfluidic selection of heterogeneous cell populations
Nathan Mathewson; Pavan Reddy
Sugar polymers exacerbate lung GVHD
Jaime L. Wiebel; Mousumi Banerjee; Daniel G. Muenz; Francis P. Worden; Megan R. Haymart
Trends in imaging after diagnosis of thyroid cancer
Scott D. Ramsey; N. Lynn Henry; Julie R. Gralow; Dana K. Mirick; William Barlow; Ruth Etzioni; David Mummy; Rahber Thariani; David L. Veenstra
Tumor marker usage and medical care costs among older early-stage breast cancer survivors